다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

OCX

Oncocyte (OCX)

Oncocyte Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OCX

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/11	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2025/02/24	20:03	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:OCX	Oncocyte Corporation
2025/02/12	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2025/02/11	22:30	GlobeNewswire Inc.	Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:OCX	Oncocyte Corporation
2025/02/10	23:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2025/02/10	23:03	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:OCX	Oncocyte Corporation
2025/02/10	22:30	GlobeNewswire Inc.	Oncocyte Prices $29.1 Million Equity Offering	NASDAQ:OCX	Oncocyte Corporation
2025/01/09	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2025/01/08	22:30	GlobeNewswire Inc.	Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer	NASDAQ:OCX	Oncocyte Corporation
2025/01/07	06:05	GlobeNewswire Inc.	Oncocyte Expands Market Opportunity for VitaGraft™ Kidney	NASDAQ:OCX	Oncocyte Corporation
2024/12/10	06:05	GlobeNewswire Inc.	Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings	NASDAQ:OCX	Oncocyte Corporation
2024/12/09	22:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2024/12/05	06:15	GlobeNewswire Inc.	Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study	NASDAQ:OCX	Oncocyte Corporation
2024/12/03	06:05	GlobeNewswire Inc.	Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms	NASDAQ:OCX	Oncocyte Corporation
2024/11/13	06:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OCX	Oncocyte Corporation
2024/11/13	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2024/11/13	06:05	GlobeNewswire Inc.	Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025	NASDAQ:OCX	Oncocyte Corporation
2024/11/07	06:45	GlobeNewswire Inc.	Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12	NASDAQ:OCX	Oncocyte Corporation
2024/10/23	05:12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:OCX	Oncocyte Corporation
2024/10/22	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:OCX	Oncocyte Corporation
2024/10/19	05:55	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:OCX	Oncocyte Corporation
2024/10/17	06:16	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:OCX	Oncocyte Corporation
2024/10/17	05:15	GlobeNewswire Inc.	Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles	NASDAQ:OCX	Oncocyte Corporation
2024/10/16	05:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2024/10/16	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2024/10/09	05:05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:OCX	Oncocyte Corporation
2024/10/08	21:30	GlobeNewswire Inc.	Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial	NASDAQ:OCX	Oncocyte Corporation
2024/10/05	08:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2024/10/03	19:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2024/10/03	07:41	GlobeNewswire Inc.	Oncocyte Signs Leading Transplant Centers in US and Germany	NASDAQ:OCX	Oncocyte Corporation

검색 관련기사 보기:NASDAQ:OCX

1 2 3 4 5 6 7 8 다음 >>

Cloudastructure

Societe Generale Effekten

BNP Paribas Issuance

ProtoSource (PK)

Intercontinental Exchange

Dogechain Token

XS2877763222 20301220 19...

BNP Paribas Issuance

BNP Paribas Issuance

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관